An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: TNBC - Triple-Negative Breast Cancer
Interventions: DRUG: A1:SG with SHR3680|DRUG: A2:SG|DRUG: B1:SG with SHR1210|DRUG: B2:SG|DRUG: C1:SG with SHR3162|DRUG: C2:SG|DRUG: D1:SG with VEGFRI|DRUG: D2:SG
Sponsor: Fudan University